European Union-Funded Project to Result in Novel Treatment Approaches for Several Solid Tumor Types
Indivumed GmbH (“Indivumed”) and CELLphenomics GmbH (“CELLphenomics”) today announced a partnership to create a unique p…
Indivumed GmbH (“Indivumed”) and CELLphenomics GmbH (“CELLphenomics”) today announced a partnership to create a unique p…
Indivumed GmbH („Indivumed“) und CELLphenomics GmbH („CELLphenomics“) geben heute ihre Partnerschaft bekannt, in der ein…
Indivumed, developer of the world’s leading discovery platform for precision oncology, and Biognosys, a leader in next-g…
Indivumed GmbH today announced the launch of the “Cancer Library Initiative”, an operation to further accelerate precisi…
Indivumed GmbH and A*STAR’s Institute of Molecular and Cell Biology (IMCB) in Singapore have signed an agreement to perf…
Indivumed, a worldwide leading biotechnical company in the field of personalized cancer medicine, and Intermed, a medica…
Die Indivumed GmbH verfügt seit heute über die ISO-9001:2008 Zertifizierung. Das Unternehmen, das Biobankprodukte, klini…